Wolverine Blend
HEALING AND REPAIRQuick Specifications
| Vial Size | 20MG |
|---|---|
| BAC Water | 2ML |
| Amount Per Unit | 0.01MG PER UNIT |
| Recommended Dose | 500MCG TO 1MG (10 TO 20 UNITS) |
| Frequency | 5-7 DAYS PER WEEK |
| Injection Type | SUBCUTANEOUS OR IM |
| Timing | Do Not Inject Near Injury Site |
Research Overview
The Wolverine Blend combines BPC-157 and TB-500, two of the most studied healing peptides in preclinical research, targeting complementary tissue repair pathways in a single vial. BPC-157 works primarily through VEGFR2 and ERK1/2 signaling to promote angiogenesis, reduce inflammatory cytokines, and activate growth hormone receptors in tendon and muscle cells. TB-500 works through G-actin sequestration to enhance cell migration, reduce fibrosis, and accelerate re-epithelialization. Together they address vascularization, cellular mobility, inflammation control, and structural tissue rebuilding simultaneously. Researchers frequently combine these peptides because their mechanisms are additive rather than redundant — BPC-157 promotes new blood vessel formation while TB-500 drives the migration of repair cells into damaged tissue. The combination has shown promise in preclinical models for musculoskeletal injuries, gut healing, skin repair, and general tissue regeneration. For research and educational purposes only. Not FDA-approved.
How It Works
Complementary Vascularization & Cell Migration
BPC-157 promotes angiogenesis (new blood vessel formation) through VEGFR2 signaling, while TB-500 drives cell migration through G-actin sequestration. These mechanisms are additive: new vessels bring repair cells to the injury site, while TB-500 ensures those repair cells migrate rapidly into damaged tissue.
Inflammation Control from Both Pathways
BPC-157 reduces inflammatory cytokines and promotes tissue-protective growth hormone receptor upregulation. TB-500's N-terminal segment (amino acids 1–4) provides independent anti-inflammatory and anti-fibrotic effects. Together they address acute inflammation while preventing excessive fibrosis.
Structural Tissue Rebuilding
BPC-157 activates ERK1/2 signaling to stimulate fibroblast activity, while TB-500 activates the Wnt/β-catenin pathway governing cell proliferation and tissue homeostasis. Both pathways converge on rebuilding the extracellular matrix and restoring tissue architecture in parallel.
Commonly Studied With
These peptides are frequently researched alongside Wolverine Blend: BPC-157 (10mg) / TB500 (10mg) due to complementary mechanisms:
Wolverine Blend: BPC-157 (10mg) / TB500 (10mg) information on this page is for research and educational purposes only. This content is not FDA-approved, does not constitute medical advice, and should not be used to guide personal health decisions. Consult a qualified healthcare professional before using any research compound.
Dose Calculator
Enter your target dose to calculate the volume to draw.
Recommended dose: 500MCG TO 1MG (10 TO 20 UNITS)